Revision: May 27, 2026, 2:41 p.m.
May 27, 2026
2026-2090-CofC
05/09
Committee of Conference Report on HB 1772-FN-A, relative to prescribing ibogaine for investigational use only.
Recommendation:
That the House recede from its position of nonconcurrence with the Senate amendment, and concur with the Senate amendment, and
That the Senate and House each pass the bill as amended by the Senate.
The signatures below attest to the authenticity of this Report on HB 1772-FN-A, relative to prescribing ibogaine for investigational use only.
Conferees on the Part of the Senate Conferees on the Part of the House
_________________________________________ _______________________________________
Sen. Rochefort, Dist. 1 Rep. W. MacDonald, Rock. 16
_________________________________________ _______________________________________
Sen. Pearl, Dist. 17 Rep. Drew, Hills. 19
_________________________________________ _______________________________________
Sen. Prentiss, Dist. 5 Rep. Markell, Rock. 18
_______________________________________
Rep. Milz, Rock. 13